Staff Spotlight: Molly Lepeska

Only when all pieces of a puzzle are assembled do you see a picture. The pieces come in different shapes and sizes, but each has a purpose—and missing one will leave an obvious gap. Only together do they form a greater whole.

Now and in the coming months, we’d like to introduce you to Health Action International’s most precious ‘puzzle pieces’: Our staff.

Insulin Still Unattainable for Many Living with Diabetes Worldwide: ACCISS Study Review in The Lancet D&E

by MOLLY LEPESKA

An ACCISS Study Review of the global insulin market, called ‘Constraints and Challenges in Access to Insulin: A Global Perspective, was published Friday in The Lancet Diabetes & Endocrinology. Co-authored by ACCISS Study leaders, David Beran, Marg Ewen and Richard Laing, the Review describes why insulin is still unattainable for approximately half of all people who need it.

HAI Launches Innovative Global Study to Improve Access to Insulin

by MARG EWEN, Global Pricing Co-ordinator and ACCISS Study Co-investigator

The global need for insulin, a hormone that converts sugar, starches and other food into needed energy for everyday activities, is immense. An estimated 100 million people with diabetes need it. This includes all with type 1 diabetes, plus 20 to 30 per cent of people with type 2 diabetes.

START TYPING AND PRESS ENTER TO SEARCH